5,6-trimethylenepyrimidin-4-one compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S253000

Reexamination Certificate

active

07470694

ABSTRACT:
Pyrimidone compounds of formula (I):are inhibitors of the enzyme Lp-PLA2and are of use in treating atheroscelerosis.

REFERENCES:
patent: 6649619 (2003-11-01), Hickey et al.
patent: 7153861 (2006-12-01), Leach et al.
patent: WO 99/24420 (1999-05-01), None
patent: WO 00/66567 (2000-11-01), None
Hickey, et al. Chemical Abstracts, vol. 135 entry 195570, 2001.
Lerman, Women and Ischemia Syndrome Evaluation (WISE) Diagnosis and Pathophysiology of Ischemic Heart Disease Workshop. Oct. 2002.
Koren, Diastolic Congestive Hearl Failure, Jacksonville Medicine. Feb. 2002.
Iribarren et at., Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Calcified Coronary Plaque in Young Adults, Arterioscler Thromb Vasc Biol., 25:216-221, Jan. 2005.
I McAllister et al., Randomised trials of secondary prevention programmes in coronary heart disease: systematic review, BMJ, vol. 323, pp. 957-962, Oct. 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5,6-trimethylenepyrimidin-4-one compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5,6-trimethylenepyrimidin-4-one compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5,6-trimethylenepyrimidin-4-one compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4050216

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.